Global pharma major Lupin Limited (Lupin) announced the launch of darunavir tablets, 600 mg and 800 mg, to market a generic equivalent of Prezista tablets of Janssen Products, LP.
Darunavir tablets, 600 mg and 800 mg (RLD Prezista) had estimated annual sales of USD 308 million in the US
Lupin is an innovation-led transnational pharmaceutical company headquartered in Mumbai, India. The company develops and commercializes a wide range of branded and generic formulations, biotechnology products, and APIs in over 100 markets in the US, India, South Africa, and across the Asia Pacific (APAC), Latin America (LATAM), Europe, and Middle East regions.
